TABLE 3b.

Vaccine-related relative risk estimates (RR) and 99% confidence intervals (CI) by Common Toxicity Criteria (CTC) in the VAERS database.

	Janssen	Moderna	Pfizer-BioNTech
CTC	RR 95% CI	RR 95% CI	RR 95% CI
Allergic	8.57 [8.15–9.01]	65.58 [62.62–68.68]	39.26 [37.47–41.13]
Arrythmia	17.77 [15.48–20.39]	56.87 [49.77–64.99]	70.80 [61.98–80.88]
Haematological	27.56 [14.19–53.55]	102.01 [53.28–195.30]	111.12 [58.07–212.65]
Cardiovascular	34.70 [27.15–44.34]	132.48 [104.13–168.53]	154.38 [121.37–196.35]
Coagulation	58.80 [37.04–93.34]	115.40 [72.94–182.59]	132.97 [84.08–210.29]
Constitutional	18.47 [17.37–19.64]	83.55 [78.74–88.66]	68.36 [64.41–72.55]
Dermatological	1.60 [1.50–1.71]	39.56 [37.74–41.47]	10.17 [9.67–10.69]
Gastrointestinal	14.47 [13.47–15.54]	62.41 [58.27–66.85]	57.76 [53.92–61.87]
Haemorraghe	16.44 [10.82–24.97]	52.62 [35.13–78.82]	61.74 [41.26–92.39]
Neurological	13.27 [12.52–14.06]	47.04 [44.51–49.72]	54.57 [51.64–57.67]
Ocular	13.03 [11.20–15.16]	40.76 [35.26–47.12]	46.51 [40.25–53.75]
Localised pain	3.95 [3.63–4.31]	37.56 [34.91–40.41]	19.57 [18.16–21.09]
Non-localised pain	9.19 [8.84–9.55]	43.79 [42.24–45.40]	38.21 [36.85–39.62]
Pulmonary	18.06 [16.20–20.15]	70.69 [63.62–78.56]	85.32 [76.80–94.80]
Renal/Genitourinary	21.16 [12.10–37.00]	99.07 [57.63–170.32]	113.13 [65.84–194.37]
Sexual organs	97.04 [51.66–182.27]	345.89 [184.90–647.06]	572.52 [306.24–1070.35]
Thrombosis	417.54 [145.56–1197.72]	659.40 [230.06–1889.96]	777.70 [271.39–2228.54]
Other reactions	9.10 [8.97–9.22]	45.71 [45.12–46.30]	44.14 [43.58–44.71]